Department of Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Langenbecks Arch Surg. 2024 Feb 12;409(1):58. doi: 10.1007/s00423-024-03244-9.
Acute necrotizing pancreatitis is still related to high morbidity and mortality rates. Minimal-invasive treatment options, such as endoscopic necrosectomy, may decrease peri-interventional morbidity and mortality. This study aims to compare the initial operative with endoscopic treatment on long-term parameters, such as endocrine and exocrine functionality, as well as mortality and recurrence rates.
We included 114 patients, of whom 69 were treated with initial endoscopy and 45 by initial surgery. Both groups were further assessed for peri-interventional and long-term parameters.
In the post-interventional phase, patients in the group of initial surgical treatment (IST) showed significantly higher rates of renal insufficiency (p < 0.001) and dependency on invasive ventilation (p < 0.001). The in-house mortality was higher in the surgical group, with 22% vs. 10.1% in the group of patients following initial endoscopic treatment (IET; p = 0.077). In long-term follow-up, the overall mortality was 45% for IST and 31.3% for IET (p = 0.156). The overall in-hospital stay and intensive care unit (ICU) stay were significantly shorter after IET (p < 0.001). In long-term follow-up, the prevalence of endocrine insufficiency was 50% after IST and 61.7% after IET (p = 0.281). 57.1% of the patients following IST and 16.4% of the patients following IET had persistent exocrine insufficiency at that point (p = < 0.001). 8.9% of the IET and 27.6% of the IST patients showed recurrence of acute pancreatitis (p = 0.023) in the long-term phase.
In our cohort, an endoscopic step-up approach led to a reduced in-hospital stay and peri-interventional morbidity. The endocrine function appeared comparable in both groups, whereas the exocrine insufficiency seemed to recover in the endoscopic group in the long-term phase. These findings advocate for a preference for endoscopic treatment of acute necrotizing pancreatitis whenever feasible.
急性坏死性胰腺炎仍然与高发病率和死亡率相关。微创治疗选择,如内镜下坏死组织清除术,可能会降低围手术期的发病率和死亡率。本研究旨在比较初始内镜治疗与初始手术治疗在长期参数(如内分泌和外分泌功能)、死亡率和复发率方面的效果。
我们纳入了 114 名患者,其中 69 名患者接受了初始内镜治疗,45 名患者接受了初始手术治疗。两组患者均进一步评估围手术期和长期参数。
在干预后阶段,初始手术治疗(IST)组患者的肾功能不全发生率明显更高(p<0.001),需要有创通气的比例也更高(p<0.001)。手术组的院内死亡率更高,为 22%,而初始内镜治疗(IET)组为 10.1%(p=0.077)。在长期随访中,IST 组的总体死亡率为 45%,IET 组为 31.3%(p=0.156)。IET 后总体住院时间和重症监护病房(ICU)住院时间明显缩短(p<0.001)。在长期随访中,IST 后内分泌功能不全的发生率为 50%,IET 后为 61.7%(p=0.281)。IST 组有 57.1%的患者和 IET 组有 16.4%的患者在此时仍存在外分泌功能不全(p<0.001)。在长期阶段,IET 组有 8.9%的患者和 IST 组有 27.6%的患者出现急性胰腺炎复发(p=0.023)。
在我们的队列中,内镜逐步治疗方法可降低住院时间和围手术期发病率。两组患者的内分泌功能似乎相似,而在外分泌功能方面,内镜组在长期阶段似乎有所恢复。这些发现支持在可行的情况下优先选择内镜治疗急性坏死性胰腺炎。